Value assessment of deprescribing interventions: Suggestions for improvement
J Am Geriatr Soc
.
2023 Jun;71(6):2023-2027.
doi: 10.1111/jgs.18298.
Epub 2023 Feb 21.
Authors
Anna Hung
1
2
3
,
Jinjiao Wang
4
,
Frank Moriarty
5
,
Veena Manja
6
7
,
Tesfahun Eshetie
8
9
,
Henok Getachew Tegegn
10
,
Timothy S Anderson
11
12
,
Thomas R Radomski
13
14
,
Michael A Steinman
15
16
Affiliations
1
Center of Innovation to Accelerate Discovery and Practice Transformation, Durham Veterans Affairs Health Care System, Durham, North Carolina, USA.
2
Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina, USA.
3
Duke-Margolis Center for Health Policy, Duke University, Durham, North Carolina, USA.
4
Elaine Hubbard Center for Nursing Research on Aging, School of Nursing, University of Rochester, Rochester, New York, USA.
5
School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland.
6
Center for Innovation to Implementation, VA Palo Alto Health Care System, Palo Alto, California, USA.
7
Department of Health Policy, Stanford University, Stanford, California, USA.
8
Registry of Senior Australians. Healthy Ageing Research Consortium, South Australian Health and Medical Research Institute, Adelaide, Australia.
9
Quality Use of Medicines and Pharmacy Research Centre, UniSA Clinical & Health Sciences, University of South Australia, Adelaide, Australia.
10
School of Rural Medicine, University of New England, Armidale, Australia.
11
Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
12
Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
13
Division of General Internal Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
14
VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, USA.
15
Division of Geriatrics, University of California San Francisco, San Francisco, California, USA.
16
San Francisco VA Medical Center, San Francisco, California, USA.
PMID:
36808728
PMCID:
PMC10258143
(available on
2024-06-01
)
DOI:
10.1111/jgs.18298
No abstract available
Publication types
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
MeSH terms
Deprescriptions*
Humans
Inappropriate Prescribing / prevention & control
Polypharmacy
Grants and funding
R24 AG064025/AG/NIA NIH HHS/United States
K24 AG049057/AG/NIA NIH HHS/United States
IK2 HX003359/HX/HSRD VA/United States
P30 AG044281/AG/NIA NIH HHS/United States
R03 AG064373/AG/NIA NIH HHS/United States
K76 AG074878/AG/NIA NIH HHS/United States
K23 AG061217/AG/NIA NIH HHS/United States